文献速递创伤与烧伤重症综合管理与镇静镇痛

战场疼痛管理:以色列国防军17年经验

Battlefield pain management: A view of 17 years in Israel Defense Forces.
PubMed 文献 · J Trauma Acute Care Surg · 2017-01-01
一句话结论以色列国防军17年战伤数据:仅12.3%伤员在负伤现场接受镇痛,最常用吗啡,无不良事件报告。

该研究回顾以色列国防军创伤登记库1997年1月至2014年12月所有在负伤现场使用镇痛药物的病例,共纳入1056例(占8576例伤员的12.3%)。伤员以男性为主(94.2%),中位年龄21岁,致伤机制以爆炸伤(40.3%)和枪弹伤(29%)为主,四肢伤占52%。共记录1469次镇痛治疗,最常用吗啡(74.7%)、芬太尼(13.6%)和氯胺酮(9.6%),39%患者接受一种以上镇痛药,90.5%由医生或急救员给药。研究期间芬太尼被引入,镇痛给药逐渐被接受并更常见;379例(35.9%)接受镇痛的患者共完成801次救生干预,未发现任何不良事件。

要点

  • 8576例伤员中仅1056例(12.3%)在负伤现场接受至少一次镇痛治疗,大多数战场伤员未获得任何镇痛。
  • 最常用镇痛药为吗啡(74.7%,1097次)、芬太尼(13.6%,200次)和氯胺酮(9.6%,141次),39%(413例)接受一种以上镇痛药。
  • 90.5%的镇痛由医生或急救员在负伤现场给药,最常见给药途径为静脉。
  • 379例(35.9%)接受镇痛的伤员共完成801次救生干预,未发现任何不良事件。
  • 研究期间(1997—2014年)芬太尼被引入,负伤现场镇痛给药逐渐被接受并更常见,更多伤员在战伤救治早期同时接受镇痛与救生干预。

适用人群与场景

  • 1997年1月至2014年12月以色列国防军创伤登记库中所有在负伤现场接受镇痛药物治疗的战伤伤员,共1056例(占8576例伤员的12.3%)。
  • 伤员94.2%为男性、5.8%为女性,中位年龄21岁;致伤机制为爆炸伤40.3%(426例)、枪弹伤29%(306例)。
  • 伤口分布:1513个受伤身体区域中四肢伤52%(787个)、躯干伤23%(353个)、头颈部伤17.7%(268个)。

处置流程与药物剂量

  • 负伤现场最常用镇痛药为吗啡(74.7%,1097次),其次为芬太尼(13.6%,200次)和氯胺酮(9.6%,141次)。
  • 39%(413例)的伤员接受了超过一种类型的镇痛药。
  • 90.5%的病例中镇痛由医生或急救员给药;最常见给药途径为静脉。

研究设计与关键结果

  • 研究类型为基于以色列国防军创伤登记库的回顾性登记研究,纳入1997年1月至2014年12月共8576例伤员中的1056例(12.3%)在负伤现场接受至少一次镇痛治疗者。
  • 共记录1469次镇痛治疗事件;吗啡1097次(74.7%)、芬太尼200次(13.6%)、氯胺酮141次(9.6%);413例(39%)接受一种以上镇痛药。
  • 379例(35.9%)接受镇痛的伤员共完成801次救生干预,未发现任何不良事件。
  • 研究期间镇痛药种类发生变化,芬太尼被引入供给药者使用;随时间镇痛给药逐渐被接受并更常见,更多伤员在战伤救治早期同时接受镇痛与救生干预。

证据类型、等级与局限

  • 证据类型:基于以色列国防军创伤登记库的登记研究(1997—2014年),样本量1056例接受镇痛的伤员。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 研究显示负伤现场大多数伤员未接受任何镇痛,而接受镇痛者中最常用阿片类药物、最常见途径为静脉,且未发现不良事件。
  • 作者希望这一镇痛给药逐渐增加的趋势能通过减少急性疼痛管理不足所致的创伤后应激障碍和总体并发症而影响战伤救治。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Pain control in trauma is an integral part of treatment in combat casualty care (CCC). More soldiers injured on the battlefield will need analgesics for pain than those who will need lifesaving interventions (LSI). It has been shown that early treatment of pain improves outcomes after traumatic injury, whereas inadequate treatment leads to higher rates of PTSD. The purpose of this article is to report the Israel Defense Forces Medical Corps (IDF-MC) experience with point of injury (POI) use of analgesia.

METHODS: All cases documented in the IDF Trauma Registry (ITR) between January 1997 and December 2014 were examined. All cases of POI pain medications were extracted. Data collection included mechanism of injury, wound distribution, pain medication administered, mortality, and provider type.

RESULTS: Of 8,576 patients, 1,056 (12.3%) patients who had at least one documented pain management treatment were included in this study. Demographics of the study population included 94.2% men and 5.8% women with a median age of 21 years. Injury mechanisms included 40.3% blast injuries (n = 426) and 29% gunshot injuries (306). Of 1,513 injured body regions reported, 52% (787) were extremity wounds (upper and lower), 23% (353) were truncal wounds, and 17.7% (268) were head and neck injuries. A total of 1,469 episodes of analgesic treatment were reported. The most common types of analgesics were morphine (74.7%, 1,097 episodes), ketamine (9.6%, 141 episodes), and fentanyl (13.6%, 200 episodes). Of the patients, 39% (413) received more than one type of analgesic. In 90.5% of cases, analgesia was administered by a physician or a paramedic. Over the span of the study period (1997-2014), types of analgesics given by providers at POI had changed, as fentanyl was introduced to providers. A total of 801 LSIs were performed on 379 (35.9%) patients receiving analgesia, and no adverse events were found in any of the casualties.

CONCLUSION: Most casualties at POI did not receive any analgesics while on the battlefield. The most common analgesics administered at POI were opioids and the most common route of administration was intravenously. This study provides evidence that over time analgesic administration has gained acceptance and has been more common place on the battlefield. Increasingly, more casualties are receiving pain management treatment early in CCC along with LSIs. We hope that this shift will impact CCC by reducing PTSD and overall morbidity resulting from inadequate management of acute pain.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Benov A, Salas MM, Nakar H, et al. Battlefield pain management: A view of 17 years in Israel Defense Forces. J Trauma Acute Care Surg. 2017. PMID: 28383472. doi:10.1097/TA.0000000000001481

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。